Theravance Biopharma Inc

Direct answer

Theravance Biopharma Inc is publicly traded on NASDAQ under the ticker TBPH.

Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, an once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD); and Ampreloxetine an investigational, once-daily norepinephrine reuptake inhibitor, Which is in Phase 3 clinical trials for symptomatic neurogenic...

Can you invest in Theravance Biopharma Inc?

Yes. Theravance Biopharma Inc is publicly traded on NASDAQ under the ticker TBPH.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Theravance Biopharma Inc

Detailed equity research is provided by MarketSnap.